The Global
Parkinson's Disease Drugs Market
Share is likely to grow in the coming years due to the growing emphasis on the treatment of Parkinson's disease. According to a report published by Fortune Business Insights, titled “Parkinson’s Disease Drugs: Global Market Analysis, Insights and Forecast, 2019-2026,” the market was valued at
US$ 4,500.0 Mn in 2018. Fortune Business Insights states that the market will reach US$ 8,383.2 Mn by 2026, thereby exhibiting a CAGR of 8.1%.
For more information in the analysis of this report, visit:
https://www.fortunebusinessinsights.com/industry-reports/parkinson-s-disease-drugs-market-100655
Detailed Table of Content:
·
Introduction
o
Research Scope
o
Market Segmentation
o
Research Methodology
o
Definitions and Assumptions
·
Executive Summary
·
Market Dynamics
o
Market Drivers
o
Market Restraints
o
Market Opportunities
o
Market Trends
·
Key Insights
o
Prevalence of Parkinson's Disease - For Key Countries, 2018
o
Regulatory Scenario - For Key Countries
o
Patent Snapshot
·
4.4 New Product Launch
o
Pipeline Analysis
o
Key Industry Developments -Mergers, Acquisitions and Partnerships
·
Global Parkinson's Disease Drugs Market Analysis, Insights and Forecast, 2014-2025
o
Key Findings / Summary
o
Market Analysis, Insights and Forecast – By Drug Class
§
Decarboxylase Inhibitors
§
DopamineAgonists
§
Monoamine Oxidase Type B (MAO-B) Inhibitors
§
Catechol-O-Methyltransferase (COMT) Inhibitors
§
Others
o
Market Analysis, Insights and Forecast – By Route of Administration
§
Oral
§
Injection
§
Transdermal
o
Market Analysis, Insights and Forecast – By Distribution Channel
§
Hospital Pharmacy
§
Retail Pharmacy
§
Online Stores
o
Market Analysis, Insights and Forecast – By Region
§
North America
§
Europe
§
Asia Pacific
§
Latin America
§
Middle East & Africa